Literature DB >> 1376598

The differential diagnosis of primary peritoneal papillary tumors.

G Gitsch1, U Tabery, W Feigl, G Breitenecker.   

Abstract

Primary tumors of the peritoneum are rare. Histological differentiation between papillary mesotheliomas, primary ovarian tumors, borderline tumors of the ovary with peritoneal deposits and primary peritoneal carcinoma may be difficult. The expression of vimentin, keratin, pankeratin, CEA, CA125, CA19-9, S100, B72.3 and BerEP4 was therefore investigated in twelve women with primary malignant peritoneal tumors, twelve women with pleural mesothelioma, eight women with serous ovarian carcinoma and four men with peritoneal mesothelioma. The marker pattern we used was no help in differentiating between metastatic ovarian carcinoma and primary peritoneal carcinomatosis. A combination of the markers S100, B72.3 and BerEP4 helped the distinction between mesotheliomas and the other malignancies. If two or all three markers are detectable, primary peritoneal carcinomatosis or metastatic ovarian carcinoma is the possible diagnosis. If none of the three markers are found, a diagnosis of mesothelioma is highly probable.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1376598     DOI: 10.1007/bf02718376

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  21 in total

1.  [Intratesticular papillary cystadenoma. A rare analogue of serous papillary cystadenoma of the ovary].

Authors:  P Meister; E Keiditsch; B Stampfl
Journal:  Pathologe       Date:  1990-05       Impact factor: 1.011

2.  Peritoneal malignant mesothelioma versus serous papillary adenocarcinoma. A histochemical and immunohistochemical comparison.

Authors:  D J Bollinger; M R Wick; L P Dehner; S E Mills; P E Swanson; R E Clarke
Journal:  Am J Surg Pathol       Date:  1989-08       Impact factor: 6.394

3.  Normal-sized ovary carcinoma syndrome.

Authors:  G A Feuer; M Shevchuk; A Calanog
Journal:  Obstet Gynecol       Date:  1989-05       Impact factor: 7.661

4.  Serous surface papillary carcinoma. A clinicopathologic study of 10 cases and comparison with stage III-IV ovarian serous carcinoma.

Authors:  S E Mills; W A Andersen; R E Fechner; M B Austin
Journal:  Am J Surg Pathol       Date:  1988-11       Impact factor: 6.394

5.  Peritoneal implants of ovarian serous borderline tumors. Histologic features and prognosis.

Authors:  D A Bell; M A Weinstock; R E Scully
Journal:  Cancer       Date:  1988-11-15       Impact factor: 6.860

6.  Multifocal extraovarian serous carcinoma. A histochemical and immunohistochemical study.

Authors:  L Resta; E Maiorano; F A Zito; F Faggiano; P Loizzi; R Ferreri; V Borraccino; R Conte; F Lucisano
Journal:  Eur J Gynaecol Oncol       Date:  1988       Impact factor: 0.196

7.  Differential diagnosis between mesotheliomas and metastatic adenocarcinomas using monoclonal antibodies against gastrointestinal carcinoma antigen and stage-specific embryonic antigen.

Authors:  C S Ernst; B Atkinson; D Chianese; J Peters; M Perry; M Herlyn; H Koprowski
Journal:  Appl Pathol       Date:  1986

8.  Serous borderline tumors of the peritoneum.

Authors:  D A Bell; R E Scully
Journal:  Am J Surg Pathol       Date:  1990-03       Impact factor: 6.394

9.  Tissue expression of CA 125 in benign and malignant lesions of ovary and fallopian tube: a comparison with CA 19-9 and CEA.

Authors:  W Neunteufel; G Breitenecker
Journal:  Gynecol Oncol       Date:  1989-03       Impact factor: 5.482

10.  Multiple focal extraovarian serous carcinoma.

Authors:  C Z August; T M Murad; M Newton
Journal:  Int J Gynecol Pathol       Date:  1985       Impact factor: 2.762

View more
  4 in total

1.  Primary peritoneal serous papillary carcinoma: a clinical and pathological study.

Authors:  Qi Liu; Jing-xian Lin; Qun-li Shi; Bo Wu; Heng-hui Ma; Gui-qin Sun
Journal:  Pathol Oncol Res       Date:  2011-06-07       Impact factor: 3.201

Review 2.  Peritoneal carcinoma in women with genetic susceptibility: implications for Jewish populations.

Authors:  Murray Joseph Casey; Chhanda Bewtra
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

Review 3.  Metastatic Carcinoma in Effusions.

Authors:  Vinod B Shidham
Journal:  Cytojournal       Date:  2022-01-31       Impact factor: 2.345

Review 4.  Metastasis in the wild: investigating metastasis in non-laboratory animals.

Authors:  Bushra Abu-Helil; Louise van der Weyden
Journal:  Clin Exp Metastasis       Date:  2019-02-09       Impact factor: 5.150

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.